home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  DRUG DISCOVERY TECHNOLOGY 2001-Europe  
  January 03, 2001

Biotechnology

 
     
  IBC Life Sciences, Messe Stuttgart International, Stuttgart, Germany
23 – 26 April 2001


This congress is now the premier focus in Europe for scientists and managers interested in all aspects of drug discovery. Participants span the range from fledgling biotechs to major pharma, and our blend of formal and informal sessions is intended to stimulate synergistic interactions throughout the conference.

With over 55 top level speakers, 80 exhibitors and more than 850 participants, Drug Discovery Technology 2001 provides an unparalleled opportunity to hear and discuss the major strategic, technology and partnering challenges that face the biopharmaceutical industry over the next decade.
 
 
Organized by: IBC Life Sciences
Invited Speakers: We are pleased to announce the following Keynote
Presentations:
* Robert Atwater, Director, NASDAQ Europe, UK
* Crispin Kirkman, Chief Executive, BIA, UK
* Dr Alfredo Aguilar-Romanillos, Head of the Cell
Factory, Research Directorate-General,
European Commission, Belgium
* Dr Peter S. Ringrose, President, Bristol Myers
Squibb, USA
* Dr Tom Wilkie, Advisor in Bioethics, The
Wellcome Trust, UK
 
Deadline for Abstracts:
 
Registration:
E-mail: ddtinfo@informa.com
 
  Posted by:   C Marshall  
Host: gatekeeper.ibcuk.co.uk
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.